𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Correlation of hepatitis B virus, hepatitis D virus and human immunodeficiency virus type I infection markers in hepatitis B surface antigen positive haemophiliacs and patients without haemophilia with clinical and histopathological outcome of hepatitis

✍ Scribed by N. Wagner; H. W. Rotthauwe; M. Becker; H. P. Dienes; T. Mertens; H. J. Födisch; H. H. Brackmann

Publisher
Springer
Year
1992
Tongue
English
Weight
628 KB
Volume
151
Category
Article
ISSN
0340-6997

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcome of patients with hepatitis B vir
Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation
✍ Norah A. Terrault; Jonathan T. Carter; Laurie Carlson; Michelle E. Roland; Peter 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB 👁 2 views

The outcome of patients with hepatitis B virus (HBV) and human immunodeficiency virus (HIV) referred for liver transplantation (LT) is unknown. A high frequency of lamivudine-resistant (LAM-R) HBV infection may increase the risk of liver-related death pre-transplantation and prophylaxis failure post

Efficacy of lamivudine in patients with
Efficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis BB
✍ Nicolaos C. Tassopoulos; Riccardo Volpes; Giuseppe Pastore; Jenny Heathcote; Mar 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 1 views

This placebo controlled, double-blind study evaluated the efficacy and safety of lamivudine in patients with hepatitis B e antigen (HBeAg)-negative/hepatitis B virus (HBV) DNA-positive chronic hepatitis B. Patients were randomized to receive 100 mg lamivudine orally once daily for 52 weeks (n ‫؍‬ 60

Elimination of hepatitis delta virus inf
Elimination of hepatitis delta virus infection after loss of hepatitis B surface antigen in patients with chronic delta hepatitis
✍ Manuel Battegay; Lisa H. Simpson; M.D. Jay H. Hoofnagle; Richard Sallie; Adrian 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 478 KB 👁 1 views

## Abstract The aim of this study was to evaluate whether patients with chronic hepatitis delta virus (HDV) infection treated with alpha interferon and subsequent loss of hepatitis B surface antigen (HBsAg) eliminate HDV. HDV RNA was detected in 26 of 28 patients with chronic delta hepatitis using

Prevalence and clinical significance of
Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea
✍ Hyoung Su Kim; Sung Jun Kim; Hye Won Park; Woon Geon Shin; Kyung Ho Kim; Jin Heo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 2 views

## Abstract Hepatitis D virus (HDV) infection can cause severe acute and chronic liver disease in patients infected with hepatitis B virus (HBV). Despite the significant decline in the global HDV infection, it remains a major health concern in some countries. This study aimed to investigate the pre